Yanping Hu
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 38
- Lung Cancer Research Studies 13
- Cancer Immunotherapy and Biomarkers 8
- Peptidase Inhibition and Analysis 6
- Colorectal Cancer Treatments and Studies 5
- Drug Transport and Resistance Mechanisms 5
- Co-authors
- Lawrence D. Mayer (7 shared papers)Jacques Robert (5 shared papers)Jon P. Durkin (1 shared paper)Robert G. Korneluk (1 shared paper)Stephen Baird (1 shared paper)Eric C. LaCasse (1 shared paper)Jun Zhao (4 shared papers)Tiantian Du (2 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Annals of Oncology (4 papers)Cancer Research (2 papers)Anti-Cancer Drugs (2 papers)Journal of Thoracic Oncology (2 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Yanping Hu
107 papers receiving 1.8k citations
Yanping Hu's Hit Papers
Peers
Comparison fields: 5 of 144
- Oncology 601
- Cancer Research 271
- Pulmonary and Respiratory Medicine 308
- Molecular Biology 692
- Biomaterials 91
Countries citing papers authored by Yanping Hu
This map shows the geographic impact of Yanping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanping Hu more than expected).
Fields of papers citing papers by Yanping Hu
This network shows the impact of papers produced by Yanping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanping Hu. The network helps show where Yanping Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yanping Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 120 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non–Small-Cell Lung Cancer Hit paper breakdown → | 2021 | 264 |
| 2 | Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. | 2003 | 198 |
| 3 | 2020 | 142 | |
| 4 | 2018 | 72 | |
| 5 | 2019 | 60 | |
| 6 | Tumor chemosensitization strategies based on apoptosis manipulations. | 2003 | 49 |
| 7 | 2006 | 46 | |
| 8 | 2020 | 43 | |
| 9 | 1996 | 36 | |
| 10 | 2023 | 36 | |
| 11 | 2016 | 32 | |
| 12 | 2022 | 31 | |
| 13 | 2017 | 30 | |
| 14 | 2024 | 29 | |
| 15 | 1995 | 28 | |
| 16 | 2004 | 26 | |
| 17 | 2019 | 26 | |
| 18 | 2022 | 26 | |
| 19 | 2015 | 24 | |
| 20 | 2018 | 24 |
About Yanping Hu
Yanping Hu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Epidemiology, having authored 120 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (19 papers), Lung Cancer Research Studies (13 papers), Cancer Immunotherapy and Biomarkers (8 papers), Peptidase Inhibition and Analysis (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Drug Transport and Resistance Mechanisms (5 papers), MicroRNA in disease regulation (5 papers) and Advancements in Battery Materials (4 papers). The work is most often cited by research in Oncology (601 citations), Cancer Research (271 citations), Pulmonary and Respiratory Medicine (308 citations), Molecular Biology (692 citations) and Biomaterials (91 citations). Yanping Hu has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Lawrence D. Mayer, Jacques Robert, Jon P. Durkin, Robert G. Korneluk, Stephen Baird, Eric C. LaCasse, Jun Zhao, Tiantian Du, Jie Wang and Wieslawa H. Dragowska. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Anti-Cancer Drugs and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.